Director of Analytical
Velesco Pharmaceutical Services
United States of America
As the Director of Pharmaceutical Chemistry for Velesco Pharmaceutical Services, Peter brings over a decade of experience working in the pharmaceutical industry. He has an extensive background in analytical method development and validation, cleaning verification and validation, project and laboratory management and management of analytical support for clinical supplies manufacturing for Phase I and Phase II clinical trials. His pharmaceutical industry experience extends across numerous types of drug product formulations including: standard immediate release capsule and tablet formulations; extended/delayed release formulations; softgel capsule formulations (encapsulations); tablets and capsules containing spray dried dispersions, spray layered dispersions, microbeads, hot-melt extrusions, spray-layered beads; IV solutions, and extemporaneously prepared solutions. Furthermore, Peter has expertise in early-stage topical, IV, and oral vehicle drug formulations for delivery of low solubility compounds. Peter joined Velesco after working for in the Pharmaceutical Sciences Division of Pfizer Global Research & Development, and several years working for Pharmacia and G.D. Searle in Analytical Development. While at Pfizer, he served as the scientific lead and technical expert for a GMP product release laboratory. Peter was also responsible for managing a group of analytical scientists and numerous scientific and technical projects supporting development of compounds from discovery to Phase III. He holds a Pharm.D. from the University of Michigan and a Ph.D. in Pharmaceutical Chemistry from the University of Kansas.